Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

1.20
Delayed Data
As of Aug 18
 -0.04 / -3.23%
Today’s Change
1.13
Today|||52-Week Range
4.62
-56.76%
Year-to-Date
Merrimack (MACK) Q2 Loss Wider than Expected, Stock Falls
Aug 10 / Zacks.com - Paid Partner Content
Merrimack's (MACK) Reports Wider-than-Expected Q2 Loss
Aug 09 / Zacks.com - Paid Partner Content